drugset / Trial / NCT04885049
Comparing the Efficacy of Anti-secretory Versus Oral Immunoglobulins for Reducing the Episodes of Diarrhea in Children
RandomizedParallel-groupSingle-blindTreatment
Summary
Children 1-12 years presenting/admitted with acute diarrhea will be enrolled in the study after taking informed consent from the parents. Patients will be randomly allocated to two equal groups. Group A (GA) will receive anti secretory 1.5mg/kg/dose, three doses in 24 hours along with oral rehydration, while Group B (GB) will receive a single dose of bovine immunoglobulins. Response to treatment will be assessed by recording the frequency of loose stools after 72 hrs. Data will be collected through a structured proforma.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2022-02-01
- Completion
- 2022-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DiaResQ Children's Powder for Suspension | Protein / enzyme biologic | 7 g | Oral |
| Subject | Racecadotril | Small molecule | 1.5 mg/kg | Oral |